Scholars Central

Review articlePublished 2016

Proteomics: An Indispensable Tool for Novel Biomarker Identification in Melanoma

Authors: Payal Mittal, Manish Jain

Journal of Data Mining in Genomics & Proteomics

Volume 7 · Issue 3 · Pages 1–10

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Melanoma is a prevalent disease with a high mortality rate. The advent of proteomics has enabled the identification of various prognostic and diagnostic melanoma biomarkers, fulfilling a vital need. The development of various protein fractionation and analysis tools has advanced the role of proteomics in analyzing complex protein samples obtained from melanoma patients. Proteomics is also being utilized to help guide drug design and the development of treatment algorithms. Ultimately, proteomics-based methodologies have proven to be paramount to the success of research being done on melanoma and the drugs used for treatment. These techniques will continue to shed light on the mechanisms of action driving therapeutic efficacy and toxicity, in hopes of extending survival and improving patient outcomes and quality of life.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Data Mining in Genomics & Proteomics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Data Mining in Genomics & Proteomics
  • SubjectBiochemistry & Biotechnology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Payal Mittal”
  • BylineArticles whose byline prints “Manish Jain”